Inari Medical CFO Mitch Hill to retire Oct 1, succeeded by Kevin Strange

Inari Medical, Inc.

Hill retires as CFO effective Oct 1, 2024; will stay in non-executive role through Jan 2, 2025 to assist transition.
Kevin Strange, current SVP Finance, Accounting, Strategy and BD, appointed new CFO effective Oct 1, 2024.
Strange compensation: $480k base salary, target bonus 60% of base, $250k RSU grant vesting over 4 years, $300k relocation bonus.
Strange has over 15 years med device finance experience; previously at Boston Scientific, Wells Fargo, and Medtronic.
Transition is orderly; Hill led IPO in May 2020 and developed Strange as successor.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kevin Strange

Chief Financial Officer

Inari Medical, Inc.

Effective: 2024-10-01
Filed: July 30, 2024, 7:59 PM ET

On July 24, 2024, the Board of Directors (the “Board”) of the Company approved the appointment of Kevin Strange as the Chief Financial Officer of the Company as of the Effective Date, succeeding Mr. Hill.

Departed

Mitch Hill

Chief Financial Officer

Inari Medical, Inc.

Effective: 2024-10-01
Successor: Kevin Strange
Filed: July 30, 2024, 7:59 PM ET

On July 24, 2024, Mitch Hill notified Inari Medical, Inc. (the “Company”) of his decision to retire as Chief Financial Officer of the Company, effective as of October 1, 2024 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kevin Strange was appointed as Chief Financial Officer at Inari Medical, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On July 24, 2024, the Board of Directors (the “Board”) of the Company approved the appointment of Kevin Strange as the Chief Financial Officer of the Company as of the Effective Date, succeeding Mr. Hill.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mitch Hill departed as Chief Financial Officer at Inari Medical, Inc..

Action: retire
Role: Chief Financial Officer

Exact text from the filing

On July 24, 2024, Mitch Hill notified Inari Medical, Inc. (the “Company”) of his decision to retire as Chief Financial Officer of the Company, effective as of October 1, 2024 (the “Effective Date”).

View on SEC.gov

Source: SEC EDGAR

accession 0001531048-24-000050

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.